-
NSE
2,007.60 2,007.60(%) -
Hitachi Energy
32,245.70 38,800.00(%) -
SBI
1,074.60 933.85(%) -
TD Power Systems
685.00 856.00(%) -
Reliance Industries
1,351.00 1,611.20(%) -
Amber Enterp.
6,909.00 8,970.00(%) -
Bharti Airtel
2,123.80 2,174.70(%) -
Larsen & Toubro
4,128.70 3,288.65(%) -
Kalyan Jewellers
684.95 327.15(%) -
SBI Funds Mgt.
512.45 433.55(%) -
Cupid
363.25 53.66(%) -
Apollo Micro Sys
477.55 477.55(%) -
M & M
3,330.00 2,743.15(%) -
3M India
28,259.25 26,400.05(%) -
Kotak Mah. Bank
484.00 345.40(%) -
Bajaj Finance
1,118.60 1,177.60(%) -
Cholaman.Inv.&Fn
1,810.15 1,299.80(%) -
Netweb Technol.
4,272.00 5,810.00(%) -
BLS Polymers
279.80 288.00(%) -
Maruti Suzuki
12,800.00 10,984.30(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs
- Aarti Group
- BSE Code : 2975.0
- ISIN : INE767A01016
-
Today’s Low
502.90 -
Today’s High
527.50
-
Open
509.20 -
Perv Close
508.75 -
52W Low
318.95 -
52W High
527.50
Key Indicators
-
P/E(TTM)
24.52
-
Mar.Cap (₹Cr.)
4,630.58
-
Div & Yield %
0.39
-
Book Value(₹)
165.78
-
Debt-Equity Ratio
-0.28
-
AGM Date
13-Nov-2026
-
EPS
20.70
-
P/E Ratio
24.52
Financials Ratios
-
Debt-Equity Ratio
0.47
-
Mar.Cap (₹Cr.)
4,630.58
-
RONW (%)
13.87
-
ROCE (%)
14.97
Score Board
-
Equity (₹ in Cr.)
91.27
-
BV (₹)
165.80
-
Sales( ₹ in Cr.)
2,260.39
-
NP (in Cr.)
169.22
-
NP Var(%)
8.0
-
Div%
20.0
-
CPS (₹)
24.60
-
EPS (₹)
18.50
-
Traded Value (₹ in Lakhs)
4,632.41
-
52 Week High
527.50
-
52 Week Low
318.95
-
Price BSE
508.0
-
Price NSE
507.00
-
Market Capital( in Cr.)
4,632.41
-
P/C Ratio
20.60
-
P/E Ratio
27.40
-
Price Vs.BV
18.50
-
15-Nov-2026( 11:04)
Corporate News - Aarti... - <p>Aarti Drugs Limited informe...
-
04-Nov-2026( 10:15)
Results - Announcements - Aarti... - <p>Aarti Drugs Ltd share price...
-
27-Oct-2026( 09:12)
Corporate News - Aarti... - <p>Aarti Drugs Limited will ho...
-
07-Oct-2026( 07:45)
Corporate News - Aarti... - <p>Aarti Drugs Limited informe...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 2,260.39 | 2,173.65 | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,260.39 | 2,173.65 | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 |
| Other Income | 2.59 | 13.57 | 4.18 | 2.23 | 4.77 | 9.69 |
| Stock Adjustments | -6.62 | -22.00 | -26.77 | 6.72 | 77.94 | 9.08 |
| Total Income | 2,256.36 | 2,165.22 | 2,244.32 | 2,506.92 | 2,333.88 | 1,933.66 |
| EXPENDITURE : | ||||||
| Raw Materials | 1,424.24 | 1,376.63 | 1,476.42 | 1,723.25 | 1,558.47 | 1,148.99 |
| Power and Fuel Cost | 170.78 | 153.51 | 151.64 | 153.45 | 126.05 | 95.64 |
| Employee Cost | 85.03 | 73.88 | 70.20 | 64.30 | 57.17 | 55.60 |
| Other Manufacturing Expenses | 222.61 | 199.25 | 201.92 | 182.71 | 171.26 | 138.99 |
| Selling and Administration Expenses | 80.32 | 74.83 | 63.27 | 89.25 | 89.75 | 76.70 |
| Miscellaneous Expenses | 8.29 | 8.37 | 7.52 | 5.68 | 5.24 | 6.72 |
| Employee Benefit Expenses | 85.03 | 73.88 | 70.20 | 64.30 | 57.17 | 55.60 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,991.28 | 1,886.48 | 1,970.96 | 2,218.64 | 2,007.95 | 1,522.64 |
| Operating Profit | 265.09 | 278.74 | 273.36 | 288.28 | 325.94 | 411.02 |
| Interest | 28.14 | 32.20 | 33.21 | 36.18 | 23.05 | 25.71 |
| Gross Profit | 236.95 | 246.54 | 240.15 | 252.10 | 302.89 | 385.31 |
| Depreciation | 55.64 | 47.79 | 47.67 | 47.29 | 47.39 | 47.60 |
| Profit Before Tax | 181.31 | 198.75 | 192.48 | 204.81 | 255.50 | 337.71 |
| Current Tax | 7.23 | 37.94 | 49.60 | 53.25 | 65.50 | 84.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.85 | 3.50 | 1.00 | -1.25 | -5.00 | -4.50 |
| Reported Net Profit | 169.22 | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 |
| Adjusted Net Profit | 169.22 | 157.31 | 141.88 | 152.81 | 195.00 | 257.54 |
| Adjustment below Net Profit | -16.92 | -15.73 | -13.32 | 0.00 | -51.64 | -69.90 |
| P & L Balance brought forward | 1,126.48 | 1,052.31 | 947.13 | 818.86 | 704.26 | 565.52 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 18.25 | 67.41 | 23.38 | 24.54 | 28.76 | 49.07 |
| P & L Balance carried down | 1,260.53 | 1,126.48 | 1,052.31 | 947.13 | 818.86 | 704.26 |
| Dividend | 0.00 | 0.00 | 9.19 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 20.00 | 10.00 | 10.00 | 10.00 | 10.00 | 25.00 |
| Dividend Per Share(Rs) | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.50 |
| Earnings Per Share-Unit Curr | 18.54 | 17.24 | 15.43 | 16.50 | 21.06 | 27.65 |
| Earnings Per Share(Adj)-Unit Curr | 18.54 | 17.24 | 15.43 | 16.50 | 21.06 | 27.65 |
| Book Value | 153.92 | 137.10 | 127.83 | 120.34 | 104.99 | 92.23 |
| Book Value(Adj)-Unit Curr | 153.92 | 137.10 | 127.83 | 120.34 | 104.99 | 92.23 |
